Ipsen S.A. buy melinda
Start price
16.01.18
/
50%
€106.40
Target price
19.03.18
€133.00
Performance (%)
16.92%
End price
19.03.18
€124.40
Summary
This prediction ended on 19.03.18 with a price of €124.40. The prediction had a final performance of 16.92%. melinda has a follow-up prediction for Ipsen S.A. where he still thinks Ipsen S.A. is a Buy. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Ipsen S.A. | 1.792% | 1.792% | 3.179% | 40.943% |
iShares Core DAX® | -1.370% | -3.231% | 11.661% | 16.545% |
iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% | 43.334% |
iShares Nikkei 225® | -0.801% | -7.859% | 18.597% | 4.253% |
iShares S&P 500 | -0.369% | -2.979% | 26.341% | 40.911% |
According to melinda what are the pros and cons of Ipsen S.A. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Ipsen S.A. diskutieren
Ipsen Oddo bestätigt seinen Rat und die objectif..133 €
2018.01.16 | 10.42
Ipsen kündigte letzte Nacht qu'Onivyde (Irinotecan Liposom zur Injektion), Cabometyx (Cabozantinib), Somatuline Autogel / Depot (lanreotide) und télotristat Ethyl (Xermelo) werden 11 Poster sein, die zwei Plakate hinzugefügt werden tun Patienten mit neuroendokrinen Tumoren während der 2018 Symposium on Gastrointestinal Cancers (ASCO-GI) der American Society of Clinical Oncology. Die Cabozantinib (Cabometyx / Nierenkrebs) wird auch mündlich präsentiert.
Nach dieser Ankündigung die Gruppe Oddo bestätigt den Vorstand über den Wert und das Kursziel von 133 E. kaufen
Nach dieser Ankündigung die Gruppe Oddo bestätigt den Vorstand über den Wert und das Kursziel von 133 E. kaufen
(Vom Mitglied beendet)
Current prediction by melinda for Ipsen S.A.
Ipsen S.A.
Start price
Target price
Perf. (%)
€105.00
13.02.24
13.02.24
€109.00
13.02.25
13.02.25
8.19%
30.04.24
30.04.24
Could be worthwhile Investment >10% per year
Stopped prediction by melinda for Ipsen S.A.
Ipsen S.A.
Start price
Target price
Perf. (%)
€105.30
08.12.22
08.12.22
€100.00
08.12.23
08.12.23
-3.04%
09.12.22
09.12.22
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€81.00
13.07.20
13.07.20
€95.00
04.11.21
04.11.21
12.32%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€116.90
04.07.17
04.07.17
€128.00
27.12.17
27.12.17
-14.03%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€116.90
04.07.17
04.07.17
€128.00
27.12.17
27.12.17
-14.03%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€99.75
24.04.17
24.04.17
€105.00
28.04.17
28.04.17
6.42%
28.04.17
28.04.17
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€90.76
13.03.17
13.03.17
€100.00
03.04.17
03.04.17
2.63%
03.04.17
03.04.17
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€77.54
20.02.17
20.02.17
€100.00
08.03.17
08.03.17
14.78%
08.03.17
08.03.17
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€49.00
14.03.16
14.03.16
€53.50
26.04.16
26.04.16
11.71%
26.04.16
26.04.16
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€34.32
16.10.14
16.10.14
€32.00
16.04.15
16.04.15
16.44%
16.04.15
16.04.15
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€27.92
20.06.10
20.06.10
€36.00
10.09.10
10.09.10
-2.49%
10.09.10
10.09.10
Could be worthwhile Investment >10% per year